Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Articles

Back to Item »

Personalized Medicine R&D 3.0: The Return of the Patient

More pharmaceutical and biotech companies are realizing the importance of patient engagement from the preclinical R&D process all the way through the commercialization phase.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »